Chugai Pharmaceutical Co., Ltd. Share Price
Stocks
4519
JP3519400000
Pharmaceuticals
OTC Markets Traded|
Delayed
Japan Exchange
04:47:10 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 6,870.00 JPY | +0.09% |
|
-4.44% | -16.72% |
| 04:33am | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| 08-14 | Japanese shares climb on bets Fed to hold rates steady; Topix poised for record close | RE |
| Market Cap | 11,293B 70.87B 61.19B 57.4B 52.28B 98.31B 6,777B 99.67B 673B 264B 3,395B 266B 260B | P/E 2026 * |
22.3x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 10,383B 65.16B 56.25B 52.78B 48.07B 90.38B 6,230B 91.64B 619B 242B 3,121B 245B 239B | EV / Sales 2026 * |
7.47x | EV / Sales 2027 * | 6.59x |
| Free-Float |
38.12% | Yield 2026 * |
1.98% | Yield 2027 * | 2.26% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +0.01% | ||
| 1 week | -4.44% | ||
| Current month | -0.97% | ||
| 1 month | -7.19% | ||
| 3 months | -12.94% | ||
| 6 months | -26.97% | ||
| Current year | -16.72% |
| 1 week | 6,832 |  | 7,229 |
| 1 month | 6,575 | | 7,509 |
| Current year | 6,575 | | 10,700 |
| 1 year | 6,002 | | 10,700 |
| 3 years | 4,197 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 28/02/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 27/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 29/02/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 27/03/2024 |
| Director/Board Member | 51 | 28/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -4.44% | +9.66% | +62.87% | 71.68B | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,052B | |
| +0.78% | +0.21% | +48.53% | +50.78% | 627B | |
| +0.35% | +0.95% | +21.11% | +66.86% | 441B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.78% | -2.68% | +24.03% | +37.32% | 287B | |
| +0.87% | -3.59% | -0.28% | +7.12% | 241B | |
| +1.00% | +0.52% | +41.46% | +58.95% | 224B | |
| -0.78% | -4.49% | -10.28% | -54.13% | 202B | |
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | |
| Average | +0.39% | -0.97% | +25.94% | +46.95% | 366.69B | |
| Weighted average by Cap. | +0.43% | -1.65% | +39.12% | +63.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,390B 8.72B 7.53B 7.07B 6.44B 12.1B 834B 12.27B 82.83B 32.46B 418B 32.75B 32.04B | 1,539B 9.66B 8.34B 7.82B 7.12B 13.39B 923B 13.58B 91.69B 35.93B 463B 36.26B 35.47B |
| Net income | 507B 3.18B 2.75B 2.58B 2.35B 4.42B 304B 4.48B 30.23B 11.85B 153B 11.96B 11.7B | 591B 3.71B 3.2B 3B 2.74B 5.14B 355B 5.22B 35.21B 13.8B 178B 13.92B 13.62B |
| Net Debt | -910B -5.71B -4.93B -4.63B -4.21B -7.92B -546B -8.03B -54.23B -21.25B -274B -21.45B -20.98B | -1,152B -7.23B -6.24B -5.85B -5.33B -10.03B -691B -10.17B -68.64B -26.9B -346B -27.14B -26.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | JP¥6,870.00 | +0.09% | 1,019,600 |
| 17/08/26 | JP¥6,864.00 | -1.00% | 1,900,800 |
| 14/08/26 | JP¥6,933.00 | -3.37% | 4,618,700 |
| 13/08/26 | JP¥7,175.00 | -0.13% | 2,369,600 |
| 12/08/26 | JP¥7,184.00 | +1.01% | 2,244,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
